Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

Maziarz M, Hagopian W, Palmer JP, Sanjeevi CB, Kockum I, Breslow N, Lernmark Å; Swedish Childhood Diabetes Register; Diabetes Incidence in Sweden Study Group; Type 1 Diabetes Genetics Consortium.

Genes Immun. 2015 Dec;16(8):541-51. doi: 10.1038/gene.2015.43. Epub 2015 Oct 29.

2.

Reply to Wilms tumor and breast cancer.

Breslow NE, Peterson SM, Green DM.

Cancer. 2015 Jun 15;121(12):2099-100. doi: 10.1002/cncr.29278. Epub 2015 Feb 24. No abstract available.

3.

Z-estimation and stratified samples: application to survival models.

Breslow NE, Hu J, Wellner JA.

Lifetime Data Anal. 2015 Oct;21(4):493-516. doi: 10.1007/s10985-014-9317-5. Epub 2015 Jan 15.

4.

Shift work and breast cancer among women textile workers in Shanghai, China.

Li W, Ray RM, Thomas DB, Davis S, Yost M, Breslow N, Gao DL, Fitzgibbons ED, Camp JE, Wong E, Wernli KJ, Checkoway H.

Cancer Causes Control. 2015 Jan;26(1):143-50. doi: 10.1007/s10552-014-0493-0. Epub 2014 Nov 25.

5.

Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study.

Lange JM, Takashima JR, Peterson SM, Kalapurakal JA, Green DM, Breslow NE.

Cancer. 2014 Dec 1;120(23):3722-30. doi: 10.1002/cncr.28908. Epub 2014 Oct 27.

6.

Individual prediction of heart failure among childhood cancer survivors.

Chow EJ, Chen Y, Kremer LC, Breslow NE, Hudson MM, Armstrong GT, Border WL, Feijen EA, Green DM, Meacham LR, Meeske KA, Mulrooney DA, Ness KK, Oeffinger KC, Sklar CA, Stovall M, van der Pal HJ, Weathers RE, Robison LL, Yasui Y.

J Clin Oncol. 2015 Feb 10;33(5):394-402. doi: 10.1200/JCO.2014.56.1373. Epub 2014 Oct 6.

7.

Using the Whole Cohort in the Analysis of Case-Control Data: Application to the Women's Health Initiative.

Breslow NE, Amorim G, Pettinger MB, Rossouw J.

Stat Biosci. 2013 Nov 1;5(2). doi: 10.1007/s12561-013-9080-2.

8.

Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China.

Li W, Ray RM, Thomas DB, Yost M, Davis S, Breslow N, Gao DL, Fitzgibbons ED, Camp JE, Wong E, Wernli KJ, Checkoway H.

Am J Epidemiol. 2013 Oct 1;178(7):1038-45. doi: 10.1093/aje/kwt161. Epub 2013 Sep 15.

9.

Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group.

Green DM, Breslow NE, D'Angio GJ, Malogolowkin MH, Ritchey ML, Evans AE, Beckwith JB, Perlman EJ, Shamberger RC, Peterson S, Grundy PE, Dome JS, Thomas PR, Kalapurakal JA.

Pediatr Blood Cancer. 2014 Jan;61(1):134-9. doi: 10.1002/pbc.24658. Epub 2013 Aug 23.

10.

Pulmonary disease after treatment for Wilms tumor: a report from the national wilms tumor long-term follow-up study.

Green DM, Lange JM, Qu A, Peterson SM, Kalapurakal JA, Stokes DC, Grigoriev YA, Takashima JR, Norkool P, Friedman DL, Breslow NE.

Pediatr Blood Cancer. 2013 Oct;60(10):1721-6. doi: 10.1002/pbc.24626. Epub 2013 Jun 14.

11.

Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor.

Ehrlich PF, Anderson JR, Ritchey ML, Dome JS, Green DM, Grundy PE, Perlman EJ, Kalapurakal JA, Breslow NE, Shamberger RC.

J Clin Oncol. 2013 Mar 20;31(9):1196-201. doi: 10.1200/JCO.2011.41.1165. Epub 2013 Feb 4.

12.

Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.

Gadd S, Huff V, Huang CC, Ruteshouser EC, Dome JS, Grundy PE, Breslow N, Jennings L, Green DM, Beckwith JB, Perlman EJ.

Neoplasia. 2012 Aug;14(8):742-56.

13.

Treatments and outcomes for end-stage renal disease following Wilms tumor.

Grigoriev Y, Lange J, Peterson SM, Takashima JR, Ritchey ML, Ko D, Feusner JH, Shamberger RC, Green DM, Breslow NE.

Pediatr Nephrol. 2012 Aug;27(8):1325-33. doi: 10.1007/s00467-012-2140-x. Epub 2012 Mar 20.

14.

Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group.

Grundy PE, Green DM, Dirks AC, Berendt AE, Breslow NE, Anderson JR, Dome JS.

Pediatr Blood Cancer. 2012 Oct;59(4):631-5. doi: 10.1002/pbc.24123. Epub 2012 Mar 15.

15.

Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3-6 years.

Sorensen JS, Vaziri-Sani F, Maziarz M, Kristensen K, Ellerman A, Breslow N, Lernmark Å, Pociot F, Brorsson C, Birkebaek NH; Danish Study Group for Childhood Diabetes.

Diabetes Res Clin Pract. 2012 May;96(2):204-10. doi: 10.1016/j.diabres.2011.12.013. Epub 2012 Jan 16.

PMID:
22251574
16.

Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Lange J, Peterson SM, Takashima JR, Grigoriev Y, Ritchey ML, Shamberger RC, Beckwith JB, Perlman E, Green DM, Breslow NE.

J Urol. 2011 Aug;186(2):378-86. doi: 10.1016/j.juro.2011.03.110. Epub 2011 Jun 17.

17.

Commentary.

Breslow NE.

Biostatistics. 2010 Jul;11(3):379-80. doi: 10.1093/biostatistics/kxq025. No abstract available.

PMID:
20538870
18.

Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study.

Green DM, Lange JM, Peabody EM, Grigorieva NN, Peterson SM, Kalapurakal JA, Breslow NE.

J Clin Oncol. 2010 Jun 10;28(17):2824-30. doi: 10.1200/JCO.2009.27.2922. Epub 2010 May 10.

19.

The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.

Maziarz M, Janer M, Roach JC, Hagopian W, Palmer JP, Deutsch K, Sanjeevi CB, Kockum I, Breslow N, Lernmark A; Swedish Childhood Diabetes Register; Diabetes Incidence in Sweden Study Group.

Genes Immun. 2010 Jul;11(5):406-15. doi: 10.1038/gene.2010.12. Epub 2010 May 6.

20.

Improved Horvitz-Thompson Estimation of Model Parameters from Two-phase Stratified Samples: Applications in Epidemiology.

Breslow NE, Lumley T, Ballantyne CM, Chambless LE, Kulich M.

Stat Biosci. 2009 May 1;1(1):32.

21.

Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5.

Shamberger RC, Anderson JR, Breslow NE, Perlman EJ, Beckwith JB, Ritchey ML, Haase GM, Donaldson M, Grundy PE, Weetman R, Coppes MJ, Malogolowkin M, Shearer PD, Kletzel M, Thomas PR, Macklis R, Huff V, Weeks DA, Green DM.

Ann Surg. 2010 Mar;251(3):555-8. doi: 10.1097/SLA.0b013e3181c0e5d7.

22.

Secondary malignant neoplasms after Wilms tumor: an international collaborative study.

Breslow NE, Lange JM, Friedman DL, Green DM, Hawkins MM, Murphy MF, Neglia JP, Olsen JH, Peterson SM, Stiller CA, Robison LL.

Int J Cancer. 2010 Aug 1;127(3):657-66. doi: 10.1002/ijc.25067.

23.

Subsets of very low risk Wilms tumor show distinctive gene expression, histologic, and clinical features.

Sredni ST, Gadd S, Huang CC, Breslow N, Grundy P, Green DM, Dome JS, Shamberger RC, Beckwith JB, Perlman EJ; Renal Tumor Committee of the Children's Oncology Group.

Clin Cancer Res. 2009 Nov 15;15(22):6800-9. doi: 10.1158/1078-0432.CCR-09-0312. Epub 2009 Nov 10.

24.

Portal hypertension in children with Wilms' tumor: a report from the National Wilms' Tumor Study Group.

Warwick AB, Kalapurakal JA, Ou SS, Green DM, Norkool PA, Peterson SM, Breslow NE.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):210-6. doi: 10.1016/j.ijrobp.2009.04.057. Epub 2009 Aug 19.

25.

Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group.

Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, Thomas PR, Grundy P, Green DM, D'Angio GJ.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):201-6. doi: 10.1016/j.ijrobp.2009.01.046.

26.

Using the whole cohort in the analysis of case-cohort data.

Breslow NE, Lumley T, Ballantyne CM, Chambless LE, Kulich M.

Am J Epidemiol. 2009 Jun 1;169(11):1398-405. doi: 10.1093/aje/kwp055. Epub 2009 Apr 8.

27.

Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group.

Huang CC, Gadd S, Breslow N, Cutcliffe C, Sredni ST, Helenowski IB, Dome JS, Grundy PE, Green DM, Fritsch MK, Perlman EJ.

Clin Cancer Res. 2009 Mar 1;15(5):1770-8. doi: 10.1158/1078-0432.CCR-08-1030. Epub 2009 Feb 10.

28.

Maternal exposure to medical radiation and Wilms tumor in the offspring: a report from the Children's Oncology Group.

Goel R, Olshan AF, Ross JA, Breslow NE, Pollock BH.

Cancer Causes Control. 2009 Aug;20(6):957-63. doi: 10.1007/s10552-009-9302-6. Epub 2009 Feb 8.

29.

Early and late mortality after diagnosis of wilms tumor.

Cotton CA, Peterson S, Norkool PA, Takashima J, Grigoriev Y, Green DM, Breslow NE.

J Clin Oncol. 2009 Mar 10;27(8):1304-9. doi: 10.1200/JCO.2008.18.6981. Epub 2009 Jan 12. Erratum in: J Clin Oncol. 2009 Oct 1;27(28):4819. Green, Daniel M [added].

30.

Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.

Fernandez CV, Anderson J, Breslow NE, Dome JS, Grundy PE, Perlman EJ, Green DM; National Wilms Tumor Study Group/Children's Oncology Group.

Pediatr Blood Cancer. 2009 Feb;52(2):254-8. doi: 10.1002/pbc.21809.

31.

Obstetric history and birth characteristics and Wilms tumor: a report from the Children's Oncology Group.

Daniels JL, Pan IJ, Olshan AF, Breslow NE, Bunin GR, Ross JA; Children's Oncology Group.

Cancer Causes Control. 2008 Dec;19(10):1103-10. doi: 10.1007/s10552-008-9174-1. Epub 2008 May 29.

33.

Islet cell autoantibody levels after the diagnosis of young adult diabetic patients.

Jensen R, Gilliam L, Torn C, Landin-Olsson M, Palmer J, Akesson K, Kockum I, Lernmark B, Karlsson AF, Lynch KF, Breslow N, Lernmark A, Sundkvist G; Diabetes Incidence Study in Sweden group.

Diabet Med. 2007 Nov;24(11):1221-8. Epub 2007 Aug 24.

PMID:
17725633
34.

Decreased core temperature and increased beta(3)-adrenergic sensitivity in diabetes-prone BB rats.

Akesson L, Hawkins T, Jensen R, Fuller JM, Breslow NE, Lernmark A.

Diabetes Technol Ther. 2007 Aug;9(4):354-62.

PMID:
17705691
35.

Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects.

Jensen RA, Gilliam LK, Törn C, Landin-Olsson M, Karlsson FA, Palmer JP, Kockum I, Akesson K, Lernmark B, Lynch K, Breslow N, Lernmark A; Diabetes Incidence Study in Sweden (DISS) group.

J Diabetes Complications. 2007 Jul-Aug;21(4):205-13.

PMID:
17616349
36.
37.

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.

Malogolowkin M, Cotton CA, Green DM, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PR, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D; National Wilms Tumor Study Group.

Pediatr Blood Cancer. 2008 Feb;50(2):236-41.

PMID:
17539021
38.

Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.

Feusner JH, Ritchey ML, Norkool PA, Takashima JR, Breslow NE, Green DM.

Pediatr Blood Cancer. 2008 Feb;50(2):242-5.

PMID:
17458877
39.

Household pesticides and the risk of Wilms tumor.

Cooney MA, Daniels JL, Ross JA, Breslow NE, Pollock BH, Olshan AF.

Environ Health Perspect. 2007 Jan;115(1):134-7.

40.

Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.

Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM.

J Clin Oncol. 2006 May 20;24(15):2352-8.

PMID:
16710034
41.

Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.

Breslow NE, Beckwith JB, Perlman EJ, Reeve AE.

Pediatr Blood Cancer. 2006 Sep;47(3):260-7.

42.

Breast-feeding and Wilms tumor: a report from the Children's Oncology Group.

Saddlemire S, Olshan AF, Daniels JL, Breslow NE, Bunin GR, Ross JA.

Cancer Causes Control. 2006 Jun;17(5):687-93.

PMID:
16633916
43.

Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.

Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PR, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D.

Pediatr Blood Cancer. 2007 May;48(5):493-9.

PMID:
16547940
44.

Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4.

Breslow NE, Beckwith JB, Haase GM, Kalapurakal JA, Ritchey ML, Shamberger RC, Thomas PR, D'Angio GJ, Green DM.

Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):203-9. Epub 2006 Mar 20.

45.

Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor.

Tomlinson GE, Breslow NE, Dome J, Guthrie KA, Norkool P, Li S, Thomas PR, Perlman E, Beckwith JB, D'Angio GJ, Green DM.

J Clin Oncol. 2005 Oct 20;23(30):7641-5.

PMID:
16234525
46.

End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System.

Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM.

J Urol. 2005 Nov;174(5):1972-5.

47.

High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.

Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, Hill DA, Breslow NE.

J Clin Oncol. 2005 Dec 20;23(36):9138-45. Epub 2005 Sep 19.

PMID:
16172460
48.

Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.

Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, Tomlinson G, Huff V, Green DM; National Wilms Tumor Study Group.

J Clin Oncol. 2005 Oct 10;23(29):7312-21. Epub 2005 Aug 29.

PMID:
16129848
49.

Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5.

Ehrlich PF, Ritchey ML, Hamilton TE, Haase GM, Ou S, Breslow N, Grundy P, Green D, Norkool P, Becker J, Shamberger RC.

J Pediatr Surg. 2005 Jan;40(1):208-12; discussion 212-3.

PMID:
15868587
50.

Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors.

Miller MA, Karacay B, Breslow NE, Li S, O'Dorisio MS, Grundy PE, Sandler AD.

J Pediatr Hematol Oncol. 2005 Jan;27(1):11-4.

PMID:
15654272

Supplemental Content

Loading ...
Support Center